Optimizing Scale-Up for Synthetic Small Molecule API
From investigational new drug ( IND ) applications through commercial scale up , BIOVECTRA has been assisting clients with small molecule projects for more than 50 years .
Experienced in a variety of complex chemistries and dedication to continuous improvement , our ability to develop and manufacture APIs through both synthetic routes and fermentation has made us a valuable long-term partner to clients .
BIOVECTRA offers :
3 cGMP facilities with network of scales from 1kg to 200MT
Expertise in controlled substances , segregated potent and non-potent handling capabilities , flow chemistry , and specialized formulation development
Specialized chemistries such as MPEG derivatives , nanoparticles , ADC payloads , and efficient purification solutions for complex molecules
Integrated process development , technical transfer , and process engineering teams with expertise in solving complex API challenges under accelerated timelines
For more information , visit us at www . BIOVECTRA . com